Second, our study highlights a distinctive difference in the effect of NDRG1 overexpression in PC cells relative to our previous findings (13) using colon and prostate cancer cells where no significant (p > 0.05) change in total GSK-3β levels or its activation was observed. This evidence concerns the gene GSK3B and prostate cancer.